Opioid Use Disorder in the Black Community: Expert Panel Discussion
A Recorded Webinar
Recorded on Friday, December 11, 2020
Jump to Course Contents
Description
Racial bias rarely protects communities of color. However, it has been noted that in the early years of the opioid epidemic, African-Americans were prescribed opioids far less often than white Americans. Researchers in the addiction profession have noted for decades that opioids were aggressively marketed in white rural areas, yet in African-American communities, prescriptions for opioids were much lower. What was the basis for this difference in prescription practices? Many scientists believe that racial biases, whether explicit or implicit, can explain the difference in care and the reason that the African-American community had lower mortality rates due to the opioid epidemic than their white counterparts. This panel will discuss some of the related research findings and the implications for BIPOC clients, as well as for our healthcare system.
Learning Objectives
- Summarize the discrepancies in opioid prescription practices between African-American communities and white Americans.
- Describe the racial biases that may explain the differences in opioid prescription practices.
- Explain the implications of racial biases in healthcare on BIPOC, as well as on our healthcare system.
Presenters
Sherrá Watkins, PhD, LCMHC-S, LCAS, CRC, CCS, BC-TMH
Sherrá Watkins, PhD, LCMHC-S, LCAS, CRC, CCS, BC-TMH, is the Director of Wellness Counseling and Assistant Professor in the Department of Behavioral Sciences at American University of the Caribbean School of Medicine. She is a leader in transforming organizational systems to increase access and utilization of counseling and coaching services that are diverse and culturally responsive. Her research focuses on decreasing the stigma of mental health and substance use disorders, chronic pain and chronic diseases among BIPOC, and the intersection of racism, racial bias, chronic pain, mental health, and substance use treatment. Watkins is the co-owner of Sister WELLS, Counseling, Coaching & Consulting, PLLC (2017) with Dr. Charla Blumell and Dr. Shawnte' Elbert. She currently resides in Saint Maarten with her husband and two boys.
Sherrá Watkins, PhD, LCMHC-S, LCAS, CRC, CCS, BC-TMH, is the Director of Wellness Counseling and Assistant Professor in the Department of Behavioral Sciences at American University of the Caribbean School of Medicine. She is a leader in transforming organizational systems to increase access and utilization of counseling and coaching services that are diverse and culturally responsive. Her research focuses on decreasing the stigma of mental health and substance use disorders, chronic pain and chronic diseases among BIPOC, and the intersection of racism, racial bias, chronic pain, mental health, and substance use treatment. Watkins is the co-owner of Sister WELLS, Counseling, Coaching & Consulting, PLLC (2017) with Dr. Charla Blumell and Dr. Shawnte' Elbert. She currently resides in Saint Maarten with her husband and two boys.
Andrew Kolodny, MD
Andrew Kolodny, MD, is the Senior Scientist at the Institute for Behavioral Health at the Heller School at Brandeis University and Medical Director of the Opioid Policy Research Collaborative. Kolodny is one of the nation's leading experts on the prescription opioid and heroin crisis. His primary area of focus is the prescription opioid and heroin crisis devastating families and communities across the country. He is also the Executive Director of Physicians for Responsible Opioid Prescribing, an organization with a mission to reduce morbidity and mortality caused by overprescribing of opioid analgesics. Kolodny previously served as Chief Medical Officer for Phoenix House, a national nonprofit addiction treatment agency and Chair of Psychiatry at Maimonides Medical Center in New York City.
Andrew Kolodny, MD, is the Senior Scientist at the Institute for Behavioral Health at the Heller School at Brandeis University and Medical Director of the Opioid Policy Research Collaborative. Kolodny is one of the nation's leading experts on the prescription opioid and heroin crisis. His primary area of focus is the prescription opioid and heroin crisis devastating families and communities across the country. He is also the Executive Director of Physicians for Responsible Opioid Prescribing, an organization with a mission to reduce morbidity and mortality caused by overprescribing of opioid analgesics. Kolodny previously served as Chief Medical Officer for Phoenix House, a national nonprofit addiction treatment agency and Chair of Psychiatry at Maimonides Medical Center in New York City.
Lamiaa Tolba, PA-C, DMSc, MPAS
Lamiaa Tolba, PA-C, DMSc, MPAS, joined Novant Cancer Institute - Hematology in April 2018 as a Certified Physician Assistant (PA-C). As a part of the Novant Cancer Institute - Hematology Team, Tolba is collaborating with Blume Pediatric Hematology Oncology Team to establish a transition program for patients with chronic non-malignant hematology condition. Tolba is an Adjunct Professor at Wingate University PA program teaching hematology to PA students. Prior to joining Novant, she worked with the sickle cell team at Levine Cancer Institute where she led and/or collaborated on a number of projects such as the Pain Action Plan and outlining the framework for the Sickle Cell Advanced Clinical Practitioner (ACP) Fellowship for the Center of Advanced Practitioners (CAP). Tolba completed her Doctorate of Medical Science (DMSc) degree from the University of Lynchburg (2019).
Lamiaa Tolba, PA-C, DMSc, MPAS, joined Novant Cancer Institute - Hematology in April 2018 as a Certified Physician Assistant (PA-C). As a part of the Novant Cancer Institute - Hematology Team, Tolba is collaborating with Blume Pediatric Hematology Oncology Team to establish a transition program for patients with chronic non-malignant hematology condition. Tolba is an Adjunct Professor at Wingate University PA program teaching hematology to PA students. Prior to joining Novant, she worked with the sickle cell team at Levine Cancer Institute where she led and/or collaborated on a number of projects such as the Pain Action Plan and outlining the framework for the Sickle Cell Advanced Clinical Practitioner (ACP) Fellowship for the Center of Advanced Practitioners (CAP). Tolba completed her Doctorate of Medical Science (DMSc) degree from the University of Lynchburg (2019).
Interactivity
Polls and Q&A.
Price
Education is FREE to all professionals.
Earn 1.5 Continuing Education Hours (CEs)
To earn a CE Certificate for viewing this webinar, you must view the webinar in its entirety, pass the CE quiz, and complete the online survey evaluation.
Click here for a complete list of organizations who approve NAADAC to provide continuing education hours.
This webinar is not eligible for ASWB ACE CE hours.
- Upon completing the webinar, you will have access to the CE quiz within the course you are taking. Find the CE quiz and click “purchase.” NAADAC members will be prompted to register for the CE quiz for free, while non-members will be prompted to pay a $20 processing fee to access the quiz.
- A score of 80% or higher is required to pass the CE quiz and access your CE certificate. You have 10 opportunities to pass the quiz. If you are unable to pass the quiz in the allocated number of tries, then you must retake the course.
- Upon passing the CE quiz, you will be required to complete the survey evaluation for the course. Once that is completed, your CE certificate will be immediately available to print. All certificates will be stored in the NAADAC Education Center under your profile name. Click here for instructions on how to access your CE certificates.
Click here for a complete list of organizations who approve NAADAC to provide continuing education hours.
This webinar is not eligible for ASWB ACE CE hours.
Who Should Attend
Addiction professionals, employee assistance professionals, social workers, mental health counselors, professional counselors, psychologists, and other helping professionals that are interested in learning about addiction-related matters.
Accessibility
Live closed captioning is available and the captioning capabilities are in compliance with the practices defined in Worldwide Web Consortium’s (W3C) Web Content Accessibility Guidelines (WCAG) and Section 508 of the Rehabilitation Act. In addition, transcripts are available for on-demand webinars recorded on and after March 27, 2019.
Questions, comments, or concerns about NAADAC Education? Take a look at our Webinar FAQs or email NAADAC.
Click here to learn about system requirements for NAADAC Webinars.
This presentation is for individual use only and may not be reproduced without permission from NAADAC.
Click here to learn about system requirements for NAADAC Webinars.
This presentation is for individual use only and may not be reproduced without permission from NAADAC.
